Bei-bei Xiao
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy, 651 Dongfeng Road East
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The value of posttreatment 18F-FDG PET/CT biomarkers for assessing response in metastatic nasopharyngeal carcinoma treated with PD-1 inhibitors.
Journal: European journal of radiology
Published: January 17, 2026
[18F] Fluorodeoxyglucose positron emission tomography/computed tomography scan and liquid biopsy at 12 weeks posttreatment for surveillance of locoregionally advanced nasopharyngeal carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 03, 2025
AK4 promotes nasopharyngeal carcinoma metastasis and chemoresistance by activating NLRP3 inflammatory complex.
Journal: Cell death & disease
Published: February 18, 2025
The prognostic value of pretreatment 18F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.
Journal: Oral oncology
Published: April 03, 2024
Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
Journal: European radiology
Published: August 12, 2022
Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 08, 2021
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
Journal: BMC cancer
Published: February 01, 2021
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 28, 2020
Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 17, 2020
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 08, 2020
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Journal: European radiology
Published: May 21, 2020
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 09, 2020
Last Updated: 09/26/2026